Considering the tremendous impact of the human microbiome on health and diseases, ranging from local intestinal diseases to systemic disorders relating to the central nervous system, systemic metabolism, and autoimmunity, it is tempting to presume that regulation of the microbiome by IgA may modulate the susceptibility of these human diseases other than infections. The gene discussed is CD79A; the disease is infection.